Drug Science

A new study by a UK-based research group, Drug Science, suggests that medical marijuana could help treat suicidal ideation. The researchers assessed about 4000 patients at the beginning of the study, but observational data was available for 2,112 patients at three months, and 777 patients for 12...

With an increase in consumption and legalization of psychedelics, cannabis and other substances in certain places around the country, there’s a growing advocacy movement stressing the importance of educating consumers.  The nonprofit Drugs and Me has a new chatbot, an...

Professor David Nutt, a cognitive sciences, addiction, cannabis and psychedelics researcher, has been ranked the #1 psychopharmacologist by ScholarGPS, a California-based American company owned and operated by Meta Analytics LLC.  According to the platform’s definition, Highly...

Can medical marijuana bring relief to those suffering from chronic pain? As per a new case study, recently published by researchers at Drug Science, cannabis could be effective in treating chronic neuropathic pain. The paper documents the case of a 61-year-old woman with idiopathic small fiber...

TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace. The goal is to gather data to better inform patients about the development of regulated psilocybin products. That way it can document...

Drug Science (UK) has selected an African company as its supplier for its medical cannabis-focused clinical research initiative, Project Twenty21. The business in question: MG Health Limited, from the Kingdom of Lesotho. According to the companies, Project Twenty21will target 20,000 U.K.-based...